Related Experiment Videos
The role of the coronary microcirculation in myocardial recovery from ischemia
Insights
Reperfusion after heart ischemia can damage the heart by increasing coronary permeability and causing microvascular plugging (no-reflow). Protecting the coronary microcirculation is crucial for improving recovery from occlusive coronary artery disease.
Area of Science:
- Cardiovascular Science
- Microcirculation Research
- Ischemia-Reperfusion Injury
Background:
- Reperfusion therapies aim to restore blood flow to ischemic myocardium but can paradoxically cause further cardiac damage.
- The coronary microcirculation is vital for myocardial recovery, facilitating nutrient and drug delivery.
- Ischemia-reperfusion injury is characterized by increased coronary permeability and microvascular plugging (no-reflow).
Purpose of the Study:
- To investigate the detrimental effects of reperfusion on the coronary microcirculation.
- To understand the mechanisms underlying ischemia-reperfusion-induced microvascular dysfunction.
- To highlight the importance of protecting the coronary microcirculation in treating occlusive coronary artery disease.
Main Methods:
- The study reviews known mechanisms of microvascular responses to ischemia and reperfusion.
- It discusses the role of increased coronary permeability and no-reflow in compromising cardiac function.
- Experimental evidence, such as the effect of calcium blockers, is considered.
Main Results:
- Reperfusion increases coronary permeability, leading to plasma protein extravasation and edema.
- Microvascular plugging (no-reflow) reduces capillary perfusion, further impairing cardiac function.
- These microvascular changes worsen over early reperfusion and depend on ischemia duration and type.
Conclusions:
- Both increased coronary permeability and no-reflow significantly compromise cardiac function post-ischemia.
- Mechanisms include cell swelling, free radical damage, inflammation, and calcium-mediated endothelial contraction.
- Protecting the coronary microcirculation should be an integral part of therapeutic strategies for occlusive coronary artery disease.
Abstract:
The aim of thrombolysis, angioplasty, and coronary artery bypass surgery is to "reperfuse" ischemic myocardium; however, reperfusion can cause further cardiac damage and compromise the coronary microcirculation. Because nutrient supply and exchange and delivery of pharmacologic agents require a patent microvasculature, the coronary microcirculation plays a major role in myocardial recovery from ischemia. It is known that ischemia-reperfusion can cause an increase in coronary permeability and microvascular plugging (No-reflow). The permeability to macromolecules is increased more than the permeability to smaller molecules. The permeability increase leads to extravasation of plasma proteins and a permeability edema. Furthermore, proteins that normally remain extravascular are now free to wash out the heart. Both microvascular effects, increased coronary permeability and No-reflow, compromise cardiac function. The degree of damage depends on the nature (No-flow versus low-flow) and length of ischemia. Unfortunately, both the increase in coronary permeability and the reduction in perfused capillarity advance with time during early reperfusion. Although the increase in permeability does not require the presence of platelets or leukocytes, it is apparent that the No-reflow response does. Mechanisms that may explain the microvascular responses to ischemia include cell swelling, damage caused by oxygen free radicals, and inflammatory responses that may or may not involve granulocytes. The permeability response may involve a calcium-mediated endothelial contraction because the macromolecular leakage that follows ischemia can be prevented by pretreating hearts with the calcium blocker nisoldipine. Protection of the coronary microcirculation should be included in any attempt to improve treatment of occlusive coronary artery disease.